Table 1.
Demographics and clinical characteristics.
| Intervention | Control | p value | |
|---|---|---|---|
| (n = 10) | (n = 8) | (Effect-size) | |
| Demographics | |||
| Age (years) | 51.10 ± 9.86 | 52.38 ± 7.44 | 0.766 (0.144) |
| Sex: Female, n (%) | 7 (70) | 6 (75) | 0.814 (0.111) |
| BMI (kg/m2) | 30.28 ± 5.20 | 37.03 ± 5.35 | 0.016 (1.280)* |
| Ethnicity: Non-Hispanic, n (%) | 7 (70) | 7 (87.5) | 0.570 (0.516) |
| Clinical characteristics | |||
| Diabetes, n (%) | 3 (30) | 3 (37.5) | 0.737 (0.158) |
| Hypertension, n (%) | 5 (50) | 3 (37.5) | 0.596 (0.252) |
| Hyperlipidemia, n (%) | 2 (20) | 3 (37.5) | 0.410 (0.079) |
| Pneumonia during COVID-19, n (%) | 4 (40) | 0 | 0.043 (1.089)* |
| Current Shortness of breath, n (%) | 2 (20) | 3 (37.5) | 0.410 (0.395) |
| Under current respiratory rehabilitation, n (%) | 2 (20) | 3 (37.5) | 0.410 (0.395) |
| Walking aid, n (%) | 4 (40) | 1 (12.5) | 0.236 (0.875) |
| Days of hospitalization (days) | 28.10 ± 27.82 | 7.75 ± 6.23 | 0.061 (0.957) |
| Supplemental oxygen during hospitalization, n (%) | 7 (70) | 5 (62.5) | 0.737 (0.159) |
| ICU admission, n (%) | 6 (60) | 3 (37.5) | 0.343 (0.459) |
| Persistency of symptoms after acute infection (days) | 295.60 ± 224.92 | 304.50 ± 179.45 | 1.000 (0.000) |
| Oxygen use at home, n (%) | 6 (60) | 1 (12.5) | 0.040 (1.107)* |
Variables are expressed as means ± standard deviation. BMI: Body mass index. COVID-19: Coronavirus disease of 2019. ICU: Intensive care unit. The asterisk denotes a significant between-group difference (p < 0.05). This table references content from the paper by Zulbaran‐Rojas et al. (2023)21.